jaimini patoliya

Ms. jaimini patoliya

Gujarat University, Ahmedabad, India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
KRKhushbu Rabadiya
Khushbu Rabadiya
DPDimple Pardhi
Dimple Pardhi
KTKhushali Thaker
Khushali Thaker
JPjaimini patoliya
jaimini patoliya
KRKiransinh Narendrasinh Rajput
Kiransinh Narendrasinh Rajput
RJRushikesh G. Joshi
Rushikesh G. Joshi

20 February 2023 in Molecular Biotechnology
Verified
Journal Article
Closed access
PDF file
JPjaimini patoliya
jaimini patoliya
KTKhushali Thaker
Khushali Thaker
KRKhushbu Rabadiya
Khushbu Rabadiya
DPDhaval Patel
Dhaval Patel
Nayan K JainNayan K Jain
Nayan K Jain
RJRushikesh G. Joshi
Rushikesh G. Joshi

31 December 2022 in VIDYA - A JOURNAL OF GUJARAT UNIVERSITY
Verified
Journal Article
Open access
PDF file
KTKhushali Thaker
Khushali Thaker
JPjaimini patoliya
jaimini patoliya
KRKhushbu Rabadiya
Khushbu Rabadiya
ZDZankruti Dholakia
Zankruti Dholakia
RJRushikesh G. Joshi
Rushikesh G. Joshi
The increasing population of Diabetes Mellitus (DM) in the world has always been concerned by physicians and scientists due to its life-threatening effects including heart diseases and premature death. Out of them, nearly 90-95% population is having type 2 diabetes mellitus (T2DM), characterised by insulin resistance. The available treatments for T2DM includes inhibition of α- glucosidase present on the brush border of human intestine that controls post-prandial hyperglycaemia by slower the releasing of glucose in the blood. Adverse effects of the available α- glucosidase inhibitors (AGI) such as abdominal discomfort and hypoglycaemia has prompted a search for the newer AGIs from natural compounds. The impact of various plant extracts on the management of medical disorders has recently aroused curiosity of researchers. Alstonia scholaris has set its hight reputation in ethnopharmacological world for treating major health issues including skin carcinoma, lung cancer and also T2DM. Though some research supports the antidiabetic activity of the plant, the mode of action responsible for it has yet to be discovered. At the same time, Catharanthus roseus has also been proved to be effective in diabetic conditions but in vitro study of antidiabetic activity of the plant is yet to be encountered. The presented study investigated different extracts of A. scholaris and C. roseus on α- glucosidase isolated from Saccharomyces cerevisiae. The presented research not only gives in-vitro proves of the plants as AGIs but also open ups new pathways in understanding the secondary metabolites as inhibitors.